Company intelligence / Profile preview

Capteur Protect

France

Ownership: Private
Development stage: Other

Overview

Capteur Protect develops and sells adhesive protective patches for securing glucose sensors, insulin pumps, and catheters. These products are marketed for people living with diabetes and are certified as medical devices. The patches enhance adhesion and longevity of continuous glucose monitoring (CGM) sensors and insulin infusion sets, are waterproof, hypoallergenic, and can last up to 7 days. The brand is available in pharmacies and direct-to-consumer.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Consumable Medical Devices

Beyond the preview

Go deeper on Capteur Protect.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capteur Protect.

Explore the full profile